Antagonistic activity of autosimbionts А. viridans, B. subtilis and their probiotic association to conditionally microflora.
DOI:
https://doi.org/10.26641/2307-0404.2015.1.40232Ключевые слова:
autosimbionts, antagonist activity, AerococcusАннотация
In this research the data on examination of antagonist qualities of bioassotiantes A. viridans and strain B. subtilis 3 towards pathogenic and opportunistic pathogenic microflora isolated from oropharynx and nasopharynx of children who were in contact with patients with pulmonary tuberculosis (MBT +) are submitted. The expressed antagonist activity of autosimbionts A. viridans towards pathogenic and opportunistic pathogenic microflora was shown. Common antagonist activity of A. viridans (k) N 1 and B. subtilis 3 towards diverse strains of test-cultures is 1,5-2 times higher, than separate antagonist activity of A. viridans (k) №1 and B. subtilis 3. Received research data showed the possibility of continuing work on development of probiotic associations, that contain representatives of normal microflora - bioassociants A. viridans and probiotic strains B. subtilis 3 with broadspectrum of antagonistic activity in relation to the various groups of bacterium.
Библиографические ссылки
Kremenchutskiy GN, Ryzhenko SA, Volyanskiy AYu. [A-bacterin in the treatment and prevention of in¬flam¬matory processes]. Dnepropetrovsk: Porogi. 2000:150. Russian. 2. Kremenchutskiy GN. [Biological features of A-bacterin]. Medichnі perspektivi. 2001;6(3):90-97. Russian. 3. Kremenchuts'kiy GM. [Culture media for de¬tection of N202, produced by microorga¬nisms].Aktual'nі pitannya іnfektsіynoї patologії. 1983;18. Ukrainian. 4. Kremenchutskiy GN, Ryzhenko SA, Val'chuk SI. [The role of micro ecology of the human body and the prin¬ciples of correction]. Dnepropetrovsk: Porogi. 2003;230. Russian. 5. Lakin GF. [Biometrics]. M. 1990;52. Russian. 6. Lelyak AA, Shternshis MV. [Antagonistic poten¬tial of Siberian strains of Bacillus spp. against pathogens of animals and plants]. Vestnik Tomskogo gosu¬darstvennogo universiteta. Biologiya. 2014;1(25): 42–55. Russian. 7. Kremenchutskiy GN, Yurgel' LG, Sharun OV, Stepans'kiy DO. [Methods for isolation and identification of gram-positive catalaze-negative cocci: guidelines]. K. 2009;19. Ukrainian. 8. About the unification of microbiological methods of research used in clinical-diagnostic laboratories of medical institutions: the Order of Ministry of health USSR № 535 from 22.04.1885. Russian. 9. Ryzhenko SA. [A new probiotic А-bacterin]. Dnepropetrovsk: Porogi. 2001;252. Russian. 10. Michail S, Sylvester F, Fuchs G, Issenman R. Clinical efficacy of probiotics: review of the evidence with focus on children. J. Pediatr. Gastroenterol. Nutr. 2006;43(4):550-7. 11. Abu-Raddad LJ. Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proceedings National Acad. Science. 2009;106(33):13980–5. 12. Stein T. Bacillus subtilis antibiotics: structures, syntheses and specific functions. Mol. Microbiol. 2005;56:845–57.
Загрузки
Опубликован
Как цитировать
Выпуск
Раздел
Лицензия
Copyright (c) 2017 Medical Perspectives
Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial» («Атрибуция — Некоммерческое использование») 4.0 Всемирная.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
